Company intelligence / Profile preview

Apceth Biopharma

Munich/Ottobrunn/Grosshadern, Bavaria, Germanyapceth.com ↗
Ownership
Private
Employees
~120
Development stage
Other
01

Overview

Apceth was one of the first companies in Europe to manufacture commercial gene therapies such as Zynteglo™ for bluebird bio. It has also completed Phase I/II trials in engineered cellular therapies for gastrointestinal cancer and somatic cell therapies for peripheral arterial occlusive disease. The company’s main business model was contract development and manufacturing of advanced therapeutic medicinal products (ATMPs) including autologous/allogeneic native or genetically modified cells, with expertise spanning from clinical to commercial scale production.

Therapeutic areas
OncologyCardiovascularHematology
Modalities
Cell therapyGene therapyStem cell therapyInduced pluripotent stem cell derived therapyCAR-T cell therapyDendritic cell therapyMesenchymal stem cell therapyHematopoietic stem cell therapy
Industry
Contract Manufacturing Organization
02

Partnerships

bluebird bio – commercial manufacturer in Europe for Zynteglo™ gene therapyIndivumed – biomarker platform development partnership

Beyond the preview

Go deeper on Apceth Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apceth Biopharma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call